These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 8036684)
1. Successful treatment of resistant visceral leishmaniasis with liposomal amphotericin B. Gokhale PC; Kshirsagar NA; Khan MU; Pandya SK; Meisheri YV; Thakur CP; Choudhary CB Trans R Soc Trop Med Hyg; 1994; 88(2):228. PubMed ID: 8036684 [No Abstract] [Full Text] [Related]
2. Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B (L-AmpB-LRC) in a child. Karande SC; Boby KF; Lahiri KR; Jain MK; Kshirsagar NA; Gokhale PC; Pandya SK Trop Doct; 1995 Apr; 25(2):80-1. PubMed ID: 7778200 [No Abstract] [Full Text] [Related]
3. Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus. Torre-Cisneros J; Villanueva JL; Kindelan JM; Jurado R; Sanchez-Guijo P Clin Infect Dis; 1993 Oct; 17(4):625-7. PubMed ID: 8268341 [TBL] [Abstract][Full Text] [Related]
4. Liposomal amphotericin B in drug-resistant visceral leishmaniasis. Davidson RN; Croft SL; Scott A; Maini M; Moody AH; Bryceson AD Lancet; 1991 May; 337(8749):1061-2. PubMed ID: 1673494 [TBL] [Abstract][Full Text] [Related]
5. [Liposomal amphotericin B cured two cases of visceral leishmaniasis tolerant to sodium antimony gluconate]. Yuan QR Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Jun; 28(3):209, 213. PubMed ID: 20806506 [No Abstract] [Full Text] [Related]
6. Treatment of kala-azar in India. Thakur CP Natl Med J India; 1992; 5(5):203-5. PubMed ID: 1338871 [No Abstract] [Full Text] [Related]
7. Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case. Gomes MAF; Medeiros LLC; Lobo FPD; Wanderley NRS; Matos APR; Jácome TDN; Monteiro MGL; Luz KG Rev Soc Bras Med Trop; 2018; 51(3):393-396. PubMed ID: 29972577 [TBL] [Abstract][Full Text] [Related]
8. Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration. Manfredi R; Marinacci G; Calza L; Passarini B Int J Antimicrob Agents; 2008 Jun; 31(6):590-2. PubMed ID: 18456464 [No Abstract] [Full Text] [Related]
9. Amphotericin B in visceral leishmaniasis. Jha BB Indian Pediatr; 1996 Nov; 33(11):971. PubMed ID: 9141838 [No Abstract] [Full Text] [Related]
10. Efficacy and tolerability of liposomal amphotericin B in Italian infants with visceral leishmaniasis. di Martino L; Raimondi F; Scotti S; Davidson RN; Gradoni L; Giacchino R Trans R Soc Trop Med Hyg; 1993; 87(4):477. PubMed ID: 8249088 [No Abstract] [Full Text] [Related]
11. [Importance of drug carriers in the treatment of visceral leishmaniasis]. Fusai T; Durand R; Boulard Y; Paul M; Bories C; Rivollet D; Houin R; Deniau M Med Trop (Mars); 1995; 55(1):73-8. PubMed ID: 7637615 [TBL] [Abstract][Full Text] [Related]
12. Amphotericin B--fat emulsion in treatment of visceral leishmaniasis--a cost effective substitute for liposomal amphotericin B. Singh GP; Saxena RK; Priyadarshy V J Indian Med Assoc; 2010 Jan; 108(1):27-8. PubMed ID: 20839576 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis in patients coinfected with the human immunodeficiency virus. Torre-Cisneros J; Villanueva JL Clin Infect Dis; 1995 Jan; 20(1):191. PubMed ID: 7727652 [No Abstract] [Full Text] [Related]
14. Treatment of visceral leishmaniasis with a 10 day course of L-ampB-LRC (Bombay), a liposomal amphotericin B. Bodhe PV; Pathare AV; Kshirsagar NA; Pandya SK J Assoc Physicians India; 1996 Mar; 44(3):222. PubMed ID: 9251329 [No Abstract] [Full Text] [Related]
15. Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar. Maheshwari A; Seth A; Kaur S; Aneja S; Rath B; Basu S; Patel R; Dutta AK Pediatr Infect Dis J; 2011 Feb; 30(2):180-1. PubMed ID: 20823781 [TBL] [Abstract][Full Text] [Related]
16. Amphotericin versus pentamidine in antimony-unresponsive kala-azar. Mishra M; Biswas UK; Jha DN; Khan AB Lancet; 1992 Nov; 340(8830):1256-7. PubMed ID: 1359322 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of intermittent liposomal amphotericin B in the treatment of visceral leishmaniasis in patients infected with human immunodeficiency virus. Laguna F; Torre-Cisneros J; Moreno V; Villanueva JL; Valencia E Clin Infect Dis; 1995 Sep; 21(3):711-2. PubMed ID: 8527591 [No Abstract] [Full Text] [Related]
18. Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex. Sundar S; Murray HW J Infect Dis; 1996 Mar; 173(3):762-5. PubMed ID: 8627049 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of liposomal amphotericin B in the treatment and secondary prophylaxis of visceral leishmaniasis in HIV infected patients: report of two cases. Lopez Dupla M; Gil Aguado A; Lavilla Uriol P; Pintado Garcia V; Valencia Ortega E; Martinez Martinez P; Garcia-Puig J J Antimicrob Chemother; 1993 Oct; 32(4):657-9. PubMed ID: 8288512 [No Abstract] [Full Text] [Related]
20. [Treatment of visceral leishmaniasis in children]. Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM Med Trop (Mars); 2007 Feb; 67(1):73-8. PubMed ID: 17506279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]